IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Avenue Therapeutics Inc

CUSIP: 05360L205 | 70 institutional holders

Quarters

Q2 2023Q1 2023Q2 2022Q1 2022Q4 2021
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2023

Shikiar Asset Management Inc25,000
0.0% of portfolio›$29
StyleTurnoverLocationFiled
Shikiar Asset Management Inc
25,000$290.0%CoreMediumNew York, NY2023-07-20